Health
Mounjaro and Zepbound: The Case for Two Hormones at Once
Tirzepatide just beat semaglutide head to head in a major trial. Here is what SURMOUNT and SURPASS data actually shows about hitting two receptors.
Dec 9, 2024
Loading
Search
Results
4 stories for“dual gip glp-1 agonist”
Health
What GLP-1 Drugs Actually Do Inside Your Body
GLP-1 receptor agonists did not start as weight loss drugs. Here is the biology behind Ozempic, Mounjaro and the hormone they mimic.
Jan 25, 2024
Health
One Receptor, Two, or Three: Comparing Semaglutide, Tirzepatide and Retatrutide
Ozempic, Mounjaro and the drug that has not arrived yet are not three versions of the same thing. They hit different receptors, produce different results, and suit different people.
Aug 11, 2026
Health
The 2026 Guidelines Quietly Removed the Hurdles People Had to Clear Before Getting an Insulin Pump
Continuous monitoring is now recommended for adults with type 2 diabetes who are not on insulin at all, and the prerequisites for starting automated insulin delivery have been deleted rather than relaxed. Both changes are about access.
Aug 15, 2026
